Navigation Links
Arigene Co., Ltd. Announces Termination of Tender Offer To Purchase and Return of Validly Tendered Shares of Common Stock of Trimeris, Inc.
Date:12/29/2009

SEOUL, South Korea, Dec. 29 /PRNewswire/ -- Arigene Co., Ltd., a Korean corporation traded on the Korean Securities Dealers Association Quotation System ("Arigene") (KOSDAQ: 067850), today announced the termination of the tender offer for the outstanding common stock of Trimeris, Inc. ("Trimeris") (Nasdaq: TRMS) by RTM Acquisition Company, a Delaware corporation and a wholly-owned subsidiary of Arigene ("RTM"), which was made pursuant to an Agreement and Plan of Merger dated as of October 2, 2009, and amended as of November 17, 2009, by and among Arigene, RTM and Trimeris, because Arigene was unable to secure sufficient financing for purposes of funding the tender offer and the merger as of the expiration time of the tender offer.

As of the expiration of the tender offer at 5:00 p.m., New York City time, on Monday, December 28, 2009, holders had tendered an aggregate of approximately 19,311,216 shares, or 86.4%, of Trimeris' common stock. None of the shares of Trimeris common stock validly tendered were purchased in the tender offer. Arigene has instructed the depositary for the tender offer to promptly return all shares of Trimeris common stock previously tendered and not withdrawn to their respective holders.

About Arigene Co., Ltd.

Arigene Co., Ltd. (KOSDAQ: 067850) is a developer, manufacturer and marketer of Ubiquitous Healthcare Systems (U-Healthcare) and related medical equipment in Korea. With its planned acquisition of Trimeris, Inc., Arigene is expanding its business to the broader biotechnology industry.

Additional Information

This press release is neither an offer to purchase nor a solicitation of an offer to sell shares of Trimeris. Arigene has filed a tender offer statement on Schedule TO, as amended, with the SEC and has mailed an offer to purchase, forms of
'/>"/>

SOURCE Arigene Co., Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Arigene Co., Ltd. Enters Into Amendment To Merger Agreement With Trimeris, Inc.
2. Vermillion Announces $43.05 Million Private Placement of Common Stock
3. ViVre Medical Announces $6,000,000 Gift
4. Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM), Its Vaccine Against Ricin Toxin
5. Maxygen, Inc. Announces Preliminary Results of Dutch Auction Tender Offer
6. Boston Scientific Announces Settlement of DOJ Investigation Relating to Post-Market Surveys Conducted By Guidant
7. Raptor Pharmaceutical Corp. Announces Closing of $7.5 Million Registered Direct Offering
8. MiMedx Group Announces Launch of its Paradis Vaso Shield(TM) Device
9. Alimera Announces Positive Results From the Two Phase 3 FAME(TM) Trials of Iluvien(R) in Patients With Diabetic Macular Edema
10. China Medicine Announces Changes to Management Team
11. PDI Announces New Pharmaceutical Services Business Win With a Top 5 Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... SETAUKET, N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, ... where its Phase I trial of Lixte,s lead compound, LB‑100, ... institutions. John S. Kovach , M.D., the ... was planned to be completed at a single site. Accrual ...
(Date:1/23/2015)... CAPE TOWN, South Africa , Jan. 23, 2015 ... and distributor of personal protective equipment for all forms ... include the flagship Leatt-Brace® neck brace, announced today that ... minicross racing federation, now requires all riders to wear ...
(Date:1/23/2015)... (NYSE: MNK ) announced today that its ... The open-ended authorization permits the company to repurchase up ... "Funding additional initiatives and seeking attractive business ... pursue a range of focused growth strategies," said ...
Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4
... Netsmart, the leading provider of clinical solutions ... announced that Dr. Dennis Morrison, a national  thought ... joined Netsmart as Chief Clinical Officer. ... will lead the Netsmart clinical team in transforming ...
... community leaders, health care professionals, and people of faith ... urged Express Scripts to get back to the ... largest pharmacy chain to return to its, network.  As ... for prescriptions filled at Walgreens and Duane Reade pharmacies. ...
Cached Medicine Technology:Dr. Dennis Morrison Joins Netsmart as Chief Clinical Officer 2Dr. Dennis Morrison Joins Netsmart as Chief Clinical Officer 3Over 200 Community Leaders and Organizations Across the Nation Urge Express Scripts To Reach Agreement With Walgreens 2
(Date:1/22/2015)... Va. (PRWEB) January 22, 2015 Liberty University ... Counseling (M.A.) program from the Council for Accreditation ... program, part of Liberty’s Center for Counseling & Family ... founding dean of the university’s new School of Behavioral Sciences. ...
(Date:1/22/2015)... The City of West Hollywood hosted a news conference on Thursday, ... of the Supreme Court decision Roe v. Wade, which legalized abortion ... Roe vs. Wade decision and the fight to protect a women’s ... of West Hollywood Councilmember Abbe Land. “We need to continue to ...
(Date:1/22/2015)... 2015 Gabe’s Chemo Duck Program is pleased to ... app ever created for kids with cancer. The Chemo Duck App, ... is filled with enjoyable games to help children of all ages ... app helps to keep kids entertained, educated and at ease while ...
(Date:1/22/2015)... 23, 2015 VogueQueen is a seasoned and ... and many designers are thrilled to have it lead the ... its new collection of prom dresses for the global market. ... the strategic vision and he focuses on continuing the goal ...
(Date:1/22/2015)... January 23, 2015 Angelweddingdress is a famous ... invites its customers to follow it on Facebook, Twitter, and ... Valentine’s Day gift. Angelweddingdress draws a lottery every week. , ... to Feb. 28, 2015. Click Angelweddingdress homepage for ...
Breaking Medicine News(10 mins):Health News:Liberty University's Resident Master’s Counseling Program Receives CACREP Accreditation 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2
... study of its kind, a team led by ... Medical Center (LA BioMed) report in November,s Psychiatric ... respond to medication for depression and were less likely ... data from the nation,s largest real-world clinical study of ...
... NORTH HOLLYWOOD, Calif., Nov. 4 IPC The,Hospitalist Company, ... group practice company, announced today that Adam D. Singer,Chief ... are scheduled to present on Wednesday, November 12, 2008 ... Phoenix, AZ., Event: 2008 Annual Credit ...
... Sponsor of the Harvard Business School Health Conference. The Conference ... Medical School, November 6 - 8, 2008. , ... ... , the world,s leading manufacturer and distributor of automated blood pressure ...
... Precise and More Comfortable for Cancer Patients, ... Cancer,Care Associates in Fresno, California have commenced treating ... Varian,Medical Systems (NYSE: VAR ) that delivers ... completed two to eight times,faster than was possible ...
... Medizone International,Inc. (Pink Sheets: MZEI) announces the ... Global, Inc. (TDVGlobal.com). TDV Global,is a highly ... 70% of their business involves consulting for,government ... enterprise,mostly in the Health and Security Medical ...
... Nov. 4 Senesco,Technologies, Inc. ("Senesco" or the ... Company will be presenting at the 10th Annual,Rodman ... at the New York,Palace Hotel from November 10-12, ... Senesco, will deliver the Company,s corporate,presentation on Tuesday, ...
Cached Medicine News:Health News:Response rates to antidepressants differ among English- and Spanish-speaking Hispanics 2Health News:IPC The Hospitalist Company, Inc. to Present at the 2008 Annual Credit Suisse Health Care Conference 2Health News:Lifeclinic International Lead Sponsor at Harvard Business School Health Conference 2Health News:Central California Doctors Now Using Fast RapidArc(TM) Radiotherapy Technology to Battle Cancer 2Health News:Central California Doctors Now Using Fast RapidArc(TM) Radiotherapy Technology to Battle Cancer 3Health News:Medizone International, Inc. Announces Strategic Consulting Relationship With TDV Global, Inc. 2Health News:Senesco Technologies to Present at 10th Annual Rodman & Renshaw Healthcare Conference 2Health News:Senesco Technologies to Present at 10th Annual Rodman & Renshaw Healthcare Conference 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: